First, TF is overexpressed on the cancer cells in many types of solid cancers [64,65,67,68,69], acute myeloid and lymphoblastic leukemia (AML and ALL), and sarcoma [64,69], as well as in Hodgkin’s lymphoma [70] and multiple myeloma [71]. Here, TF is linked to cancer.